TXNRD1 and glioblastoma: Similarly, Tang et al. [47] reported that thioredoxin reductase 1 (TrxR1) inhibition triggers disulfidptosis in glioblastoma (GBM) by disrupting redox homeostasis, leading to cytoskeletal collapse and immunogenic cell death.